GSK‐3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objectives: Lithium (Li+) has been suggested to target the enzyme glycogen synthase kinase 3 (GSK‐3) as a mechanism of mood stabilization. Inhibition of GSK‐3 by a second mood‐stabilizer, valproic acid (VPA), has also been reported, but this effect is dependent on cell type. It is currently unknown if carbamazepine (CBZ) inhibits GSK‐3 activity. We have sought to compare the inhibitory effect of Li+, VPA and CBZ on GSK‐3 activity. Methods: We treated rat primary cultured neurones at three times therapeutic drug concentration with CBZ, VPA and Li+ and examined changes in GSK‐3 protein levels, activity and phosphorylation of downstream targets. To eliminate a possible direct effect of these drugs at higher concentrations, we also looked for direct inhibition of both GSK‐3 isoforms at a range of concentrations. Results: CBZ, VPA and Li+ did not change the levels of the GSK‐3 or produce an irreversible in vivo effect on GSK‐3 activity. Only Li+ inhibited the phosphorylation of a cytoskeletal target of GSK‐3, tau, whereas CBZ and VPA did not. Surprisingly, none of these drugs altered β‐catenin levels in these cells, a process attenuated by GSK‐3 activity. Finally, only Li+ directly inhibits GSK‐3 activity (both α and β isoforms) at therapeutic levels in direct biochemical assays. Conclusion: Thus we show that neither GSK‐3 nor the altered GSK‐3 signalling pathway can provide a common mechanism of action of mood‐stabilizing drugs in the mammalian brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758 · cited 5×
“This is consistent with different effects of these drugs on cultured cell lines from those seen with primary neurones, possibly due to VPA’s inhibition of HSDA (10).”
BackgroundMethodInfluentialLithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Glycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cells
Sperbera, B. R., Leight, S., Goedert, M., & Lee, V. M.-Y. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11902-9 · Cited by 204
Cited by
Lithium delays progression of amyotrophic lateral sclerosis
Fornai, F., Longone, P., Cafaro, L., Kastsiuchenka, O., Ferrucci, M., Manca, M. L., Lazzeri, G., Spalloni, A., Bellio, N., Lenzi, P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708022105 · Cited by 550
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Rosenberg, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7079-x · Cited by 300
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
Li, X., & Jope, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.105 · Cited by 294
“No evidence has been reported for inhibition of GSK3 by carbamazepine (Aubry et al, 2009; Mai et al, 2002; Ryves et al, 2005); one study in cultured cells found no effect of lamotrigine on GSK3 serine phosphorylation (Aubry et al, 2009); whereas chronic treatment (28 days) of mice with lamotrigine…”
Metadata
- Authors
- Jonathan Ryves, W., Dalton, E. C., Harwood, A. J., & Williams, R. S.
- Venue
- Bipolar Disorders
- Publisher
- Wiley
- Published
- 2005-05-17
- Volume
- 7
- Issue
- 3
- Pages
- 260-265
- ISSN
- 1398-5647 (ISSN-L)
- 1399-5618
- OpenAlex
- W2134773980
- Cited by
- 60
- References
- 3
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GSK‐3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid. https://app.cochat.ai/papers/10.1111/j.1399-5618.2005.00194.x
- The paper
- Jonathan Ryves, W., Dalton, E. C., Harwood, A. J., & Williams, R. S. (2005). GSK‐3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2005.00194.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.